Physicians are an essential part of our work. We partner with more than 500 healthcare professionals who provide cancer treatment in low- and middle-income countries. They volunteer to be in our program, caring for people in need on top of their regular schedule.
Dr. Mipsang Lama is a perfect example – he goes above and beyond for his patients. He partnered with The Max Foundation in July 2023. In addition to treating diseases like chronic myeloid leukemia (CML) and providing personalized care, Dr. Mipsang is an active participant in Patient Support Group Meetings.
Born in Nepal, he attended school in Kathmandu and Bhairahawa and specializes in internal medicine and clinical hematology. Dr. Mipsang is also an assistant professor at the Patan Academy of Health Sciences, as well as a husband and father to two sons.
Education is a priority for Dr. Mipsang. He wants the 77 active patients under his care to fully understand their diagnosis so they can make informed decisions about their treatment. He offers counseling and support and is readily available for emergencies.
This extends to Patient Support Group Meetings as well. Dr. Mipsang gives presentations on the entire process, from diagnosis to transitional care. He also takes time to meet with Max team members, sharing ideas for strengthening our program and reaching more patients. Dr. Mipsang’s dedication is making a real difference in the lives of people living with cancer in Nepal.
The Max Foundation is a leading global health nonprofit organization dedicated to accelerating health equity. For 28 years, Max has pioneered practical, scalable, high-quality solutions to bring life-extending treatments and patient-centered health care to more than 100,000 people living with cancer and critical illness in low- and middle-income countries. Max believes in a world where all people can access high-impact medicines, where geography is not destiny, and where everyone can strive for health with dignity and with hope.
A new study in Clinical Epidemiology and Global Health features the Glivec®Patient Assistance Program (GIPAP) and reveals that “chronic myelocytic leukemia (CML) is diagnosed at an earlier age in poorer populations than in more affluent populations.” The study focused on India’s CML population to investigate other possible contributors to early age at onset. The team of authors….
Surviving cancer in countries that lack the support and care, the word empowerment is not in patients’ dictionaries. But if we could increase the access to treatment and care in these countries, can we turn the tables?
People living with cancer deserve access to holistic treatment, including support, education, and the opportunity to connect with others in a similar situation. That’s why The Max Foundation and its partners offer more than just medicine. Sandra from Chile started participating in our treatment adherence program, Day by Day, after being diagnosed with chronic myeloid….
